In a filing, Vanda Pharmaceuticals Inc revealed its SVP, CFO & Treasurer Moran Kevin Patrick unloaded Company’s shares for reported $13327.0 on Jul 29 ’24. In the deal valued at $5.92 per share,2,251 shares were sold. As a result of this transaction, Moran Kevin Patrick now holds 228,763 shares worth roughly $1.37 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Polymeropoulos Mihael Hristos sold 24,288 shares, generating $100,273 in total proceeds. Upon selling the shares at $4.13, the President and CEO now owns 1,871,730 shares.
Before that, Wijkstrom Joakim sold 9,229 shares. Vanda Pharmaceuticals Inc shares valued at $38,830 were divested by the SVP, Chief Marketing Officer at a price of $4.21 per share. As a result of the transaction, Wijkstrom Joakim now holds 129,789 shares, worth roughly $0.78 million.
Cantor Fitzgerald initiated its Vanda Pharmaceuticals Inc [VNDA] rating to an Overweight in a research note published on July 11, 2024; the price target was $11. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in late February from “a Buy” to “a Hold”. BofA Securities began covering VNDA with “Buy” recommendation on May 12, 2021. Citigroup revised its rating on January 14, 2021. It rated VNDA as “a Neutral” which previously was an “a Buy”.
Price Performance Review of VNDA
On Monday, Vanda Pharmaceuticals Inc [NASDAQ:VNDA] saw its stock fall -2.91% to $6.00. Over the last five days, the stock has lost -5.36%. Vanda Pharmaceuticals Inc shares have risen nearly 42.18% since the year began. Nevertheless, the stocks have fallen -7.12% over the past one year. While a 52-week high of $6.75 was reached on 06/13/24, a 52-week low of $3.30 was recorded on 02/06/24. SMA at 50 days reached $5.72, while 200 days put it at $4.55. A total of 0.62 million shares were traded, compared to the trading of 0.36 million shares in the previous session.
Levels Of Support And Resistance For VNDA Stock
The 24-hour chart illustrates a support level at 5.86, which if violated will result in even more drops to 5.73. On the upside, there is a resistance level at 6.17. A further resistance level may holdings at 6.35. The Relative Strength Index (RSI) on the 14-day chart is 52.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 29.55%. Stochastics%K at 79.35% indicates the stock is a holding.
